Pharmaceutical

Amarin restructures to counter downturn following Vascepa generics

Amarin Corporation has initiated a company restructuring programme, following a business review by its new board and senior management team.

Jul 19, 2023 - 20:00
Amarin restructures to counter downturn following Vascepa generics
Amarin Corporation has initiated a company restructuring programme, following a business review by its new board and senior management team.
Read the original article

Tags:

Previous Article

Pieris Pharma lays off 70% of workforce amid company restructuring

Next Article

US DoD enlists VitriVax to develop one-shot vaccine for melioidosis

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pfizer announces drop in reported net income in Q2 2023

Pfizer announces drop in reported net income in Q2 2023

Aug 2, 2023

STAT+: He’s 19 months old and has one of the world’s rarest diseases. His parents are determined to find a cure.

STAT+: He’s 19 months old and has one of the world’s ra...

Mar 4, 2024

STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition

STAT+: Bayer’s promising menopause drug trial results h...

Jan 10, 2024